| 发明名称 | Treatment of short bowel syndrome patients with colon-in-continuity | ||
| 摘要 | Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide. | ||
| 申请公布号 | US9603902(B2) | 申请公布日期 | 2017.03.28 |
| 申请号 | US201615286171 | 申请日期 | 2016.10.05 |
| 申请人 | SHIRE-NPS PHARMACEUTICALS, INC. | 发明人 | Sanguinetti Elizabeth L.;Marriott Thomas B.;Lopansri Jennifer;Blosch Consuelo M. |
| 分类号 | A61K38/16;C07K14/00;A61K38/26;A61K9/00 | 主分类号 | A61K38/16 |
| 代理机构 | Troutman Sanders LLP | 代理人 | Troutman Sanders LLP |
| 主权项 | 1. A method of reducing rapid gastric emptying of a patient having short bowel syndrome and rapid gastric emptying, who receives parenteral nutrition each week, and who presents with colon-in-continuity with remnant small intestine, said method comprising administering [Gly2]hGLP-2 to said patient using a dosing regimen effective to reduce the speed of gastric emptying. | ||
| 地址 | Bedminster NJ US | ||